NEUROENDOCRINE (NE) TUMORS
Clinical trials for NEUROENDOCRINE (NE) TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE (NE) TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE (NE) TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New scan agent aims to light up hard-to-find cancers
Diagnosis TerminatedThis study was designed to see if a new radioactive imaging agent (111In-ABD147) can help detect metastatic solid tumors, including prostate cancer and neuroendocrine tumors. The agent targets a protein called DLL3 found on many cancer cells. The trial was withdrawn before enroll…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated May 01, 2026 15:59 UTC
-
New PET scan slashes radiation by 100x – could change imaging forever
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new, ultra-low-dose PET scan that uses 10 to 100 times less radiation than current scans. Researchers want to see if they can still get clear images of brain conditions (like Parkinson's) and certain tumors. About 200 healthy volunteers and patients will get on…
Matched conditions: NEUROENDOCRINE (NE) TUMORS
Phase: PHASE2 • Sponsor: Akiva Mintz • Aim: Diagnosis
Last updated Apr 29, 2026 15:05 UTC